SkinStylus microneedling is expanding into Europe. SkinHealth Systems, the Nasdaq-listed parent of Hydrafacial, announced on October 1, 2026 that its SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device intended for cosmetic use, is now available in the UK, Ireland, Germany, France, Spain and Portugal.
According to the company’s announcement, SkinStylus will be sold through SkinHealth Systems’ direct European commercial organization, and availability is expected to extend into select distributor markets beginning in 2027.
Key Takeaways: SkinStylus Microneedling Europe Expansion
- The SkinStylus SteriLock MicroSystem is now available in six European markets: the UK, Ireland, Germany, France, Spain and Portugal.
- It is a professional device for trained aesthetic professionals and is intended for cosmetic use only.
- The device offers adjustable settings and multiple SteriLock cartridge options, and nano-needling treatments may help enhance absorption of professional topical skincare products, the company says.
- SkinHealth Systems will sell it through its own European commercial team, using the Hydrafacial footprint, with select distributor markets expected from 2027.
- The company bought SkinStylus in 2023 to broaden its portfolio beyond Hydrafacial.
What Is the SkinStylus SteriLock MicroSystem?
The SkinStylus SteriLock MicroSystem is a professional microneedling and nano-needling device for cosmetic skin treatments. It is designed for precision and consistency, with adjustable settings and a range of SteriLock cartridges that let trained aesthetic professionals tailor each treatment to a client’s cosmetic skin concerns, needs and desired outcomes.
SkinStylus Microneedling Europe Launch at a Glance
| Item | Detail |
|---|---|
| Company | SkinHealth Systems (Nasdaq: SKIN), home to Hydrafacial |
| Announced | October 1, 2026 |
| Product | SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device |
| Available now | UK, Ireland, Germany, France, Spain and Portugal |
| Sales channel | SkinHealth Systems’ direct European commercial organization |
| Next step | Select distributor markets expected to begin in 2027 |
| Intended use | Cosmetic use by trained aesthetic professionals |
How SkinHealth Systems Plans to Sell SkinStylus in Europe
SkinHealth Systems chief executive Pedro Malha said expanding SkinStylus internationally is an important step in building the company into a broader medical aesthetics ecosystem. By using the strength of the Hydrafacial device footprint and its established provider relationships, he said, the company can bring providers complementary technologies for a wider range of cosmetic skin concerns and create more opportunities to serve their clients.
In practice, that means the same European sales organization that supports Hydrafacial will introduce SkinStylus to aesthetic professionals across the six launch countries. Distributor-led sales in additional markets are not expected until 2027.
Why Europe, and Why Now
SkinHealth Systems says the launch builds on growing global interest in professional microneedling and supports its strategy of offering complementary solutions for a broad range of skin concerns, needs and treatment goals. Hydrafacial already has a European presence: in 2023 the company said it was launching its Hydrafacial Syndeo device across key European and Asia-Pacific markets, and SkinStylus lets the same sales team offer providers a second treatment category.
Background: SkinHealth Systems, Hydrafacial and the 2023 Acquisition
SkinHealth Systems describes itself as a global medical aesthetics company that combines device technology, proprietary consumables and clinical validation. Alongside Hydrafacial, its portfolio includes SkinStylus microneedling and HydraScalp with Keravive. The company, previously known as The Beauty Health Company, acquired SkinStylus in 2023, describing it at the time as an FDA-cleared microneedling device and one of the most complementary co-treatments to Hydrafacial.
What Professional Microneedling and Nano-Needling Involve
Professional microneedling uses fine needles to create controlled, superficial skin punctures during a cosmetic treatment performed by a trained practitioner. Nano-needling works at a shallower depth. SkinHealth Systems says nano-needling with SkinStylus may help enhance the absorption of professional topical skincare products applied during treatment, which is a company statement rather than a result from published clinical data.
What Is Not Yet Known
The announcement does not describe the device’s European regulatory marking, pricing, or clinical evidence for the European launch. In its forward-looking statements, SkinHealth Systems also cautions that the success of the launch and how products are received by providers and consumers in each country are uncertain. In our assessment, the strategy of cross-selling to existing Hydrafacial providers is logical, but adoption will depend on how well SkinStylus performs commercially against established microneedling devices.
What Providers Should Check Before Adopting a Device
For clinics considering any professional microneedling device, general due diligence includes confirming the device’s regulatory status in their own country, local training and licensing rules for practitioners, the cost and supply of single-use cartridges and consumables, and infection-control and aftercare protocols. SkinHealth Systems did not publish pricing, training requirements or regulatory details with this announcement, so providers should request them directly.
What It Means for Clinics and Consumers
SkinStylus is a professional device that is used by trained aesthetic professionals, not a consumer product. People considering microneedling should consult a qualified practitioner about suitability, risks and aftercare. For related coverage of medical technology launches, read our reports on Singapore’s autonomous dental implant robot, Mindray’s SV70 ventilator and Epredia’s automated tissue archiving, or browse our medical device news.
Frequently Asked Questions About SkinStylus Microneedling
Where is SkinStylus now available in Europe?
SkinStylus is available in the UK, Ireland, Germany, France, Spain and Portugal, according to SkinHealth Systems.
What is the SkinStylus SteriLock MicroSystem?
It is a professional microneedling and nano-needling device intended for cosmetic use, with adjustable settings and multiple SteriLock cartridge options.
Who sells SkinStylus in Europe?
SkinHealth Systems sells it through its direct European commercial organization, which also supports Hydrafacial. Select distributor markets are expected from 2027.
Who owns SkinStylus?
SkinHealth Systems, the Nasdaq-listed parent of Hydrafacial, acquired SkinStylus in 2023.
Is SkinStylus for medical treatment?
No. The company says the device is intended for cosmetic use by trained aesthetic professionals.
How we reported this: this article is based on SkinHealth Systems’ announcement and the company’s 2023 acquisition release linked above. Performance claims are the company’s own and are not clinical findings. Last updated October 2, 2026. It is for information only and is not medical advice.
